Proceedings: Preliminary studies of Ro 3-3528, a beta-adrenoceptor-blocking agent, in man.
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D001572:Benzofurans / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D004983:Ethanolamines / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D006207:Half-Life; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D010919:Placebos; D011433:Propranolol / Q000008:administration & dosage / Q000494:pharmacology*; D011437:Propylamines / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D001572:Benzofurans; D004983:Ethanolamines; D010919:Placebos; D011437:Propylamines; D011433:Propranolol